The Belgian Eisenmenger syndrome registry: Implications for treatment strategies?

Acta Cardiologica

Volumn 64, Issue 4, 2009, Pages 447-453

  Van De Bruaene, Alexander ^a   Delcroix, Marion ^a   Pasquet, Agnes ^b   De Backer, Julie ^c   De Pauw, Michel ^c   Naeije, Robert ^d   Vachiéry, Jean Luc ^d   Paelinck, Bernard ^e   Morissens, Marielle ^f   Budts, Werner ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Congenital heart disease; Down syndrome; Eisenmenger syndrome; Epidemiology; Pulmonary hypertension; Registry

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BELGIUM; DISEASE ASSOCIATION; DOWN SYNDROME; EISENMENGER COMPLEX; FEMALE; FUNCTIONAL STATUS; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REGISTER; TREATMENT PLANNING;

ADOLESCENT; ADULT; BELGIUM; DOWN SYNDROME; EISENMENGER COMPLEX; HEART SEPTAL DEFECTS; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; PREVALENCE; REGISTRIES;

EID: 69249154305     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.4.2041608     Document Type: Article

References (30)

1. Duffels MGJ, Engelfriet PM, Berger RMF, van Loon RLE, Hoendermis E, Vriend JWJ, van der Velde ET, Bresser P, Mulder BJM. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J of Card 2007; 120: 198-204. (Pubitemid 47042253)
2. Bouzas B, Gatzoulis MA. Pulmonary arterial hypertension in adults with congenital heart disease. Rev Esp Cardiol 2005; 58: 465-469 (Pubitemid 40894714)
3. Report of the British Cardiac Society Working Group. Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart 2002; 88: i1-i14.
4. Engelfriet P, Tijsen J, Kaemmerer H, Gatzoulis MA, Boersma E, Oechslin E, Thaulow E, Popelova J, Moons P, Meijboom F, Daliento L, Hirsch R, Laforest V, Thilen U, Mulder B. Adherence to clinical guidelines in the clinical care for adults with congenital heart disease: The Euro Heart Survey on Adult Congenital Heart Disease. Eur Heart J 2006; 27: 737-745
5. van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results. Eur J Epidemiol 2005; 20: 549-557 (Pubitemid 40933933)
6. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilén U, Kaemmerer H, Moons P, Meijboom F, Popelová J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005; 26: 2325-2333
7. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary aerterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030
8. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Resp J 2007; 30: 104-109 (Pubitemid 47074013)
9. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-1050 (Pubitemid 46328298)
10. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278
11. Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A, Branzi A, Picchio FM. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008; 68: 1049-1066 (Pubitemid 351693675)
12. Chan SY, Loscalzo J. Pathogenic mechanisms for pulmonary arterial hypertension. J Mol Cell Cardiol 2008; 44: 14-30.
13. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000; 86: 1111-1116 (Pubitemid 30802221)
14. Engelfriet P, Duffels MGJ, Möller T, Boersma E, Tijssen JGP, Thaulow E, Gatzoulis MA, Mulder BJM. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2007; 93: 682-687 (Pubitemid 46808265)
15. Daliento L, Sommerville J, Presbitero P, Menti L, Brach-Prevert S, Rizzoli G, Stone S. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-1855
16. Chin KM, Kim NHS, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005; 16: 13-18
17. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002; 89: 34-38
18. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital heart disease. Circulation 1958; 18: 533-547
19. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903. (Pubitemid 34984638)
20. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48-54.
21. Chau EM, Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol 2007; 120: 301-305 (Pubitemid 47069563)
22. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006; 27: 1737-1742 (Pubitemid 44025362)
23. Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, McLaughlin PR, Siu SC. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999; 84: 677-681 (Pubitemid 29417960)
24. Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, Khourthy M, Saker DM. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80: 213-217 (Pubitemid 28533530)
25. Yamaki S, Yasui H, Kado H, Yonenaga K, Nakamura Y, Kikuchi T, Ajiki H, Tsunemoto M, Mohri H. Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. J Thorac Cardiovasc Surg 1993; 106: 398-405. (Pubitemid 23277608)
26. Clapp S, Perry BL, Farooki ZQ, Jackson WL, Karpawich PP, Hakimi M, Arciniegas E, Green EW, Pinsky WW. Down's syndrome, complete atrioventricular canal and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 1990; 100: 115-121 (Pubitemid 20213610)
27. Bull C, Rigby ML, Shinebourne EA. Should management of complete atrioventricular canal defect be influenced by coexistent Down syndrome? Lancet 1985; 1: 117-149
28. Al-Hay AA, MacNeill SJ, Yacoub M, Yacoub M, Shore DF, Shinebourne EA. Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors. Ann Thorac Surg 2003; 75: 412-421
29. Lange R, Guenther T, Busch R, Hess J, Schreiber C. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 2007; 134: 304-310 (Pubitemid 47088564)
30. Duffels MG, Vis JC, van Loon RLE, Berger RM, Hoendermis ES, van Dijk AP, Bouma BJ, Mulder BJ. Down patients with Eisenmenger syndrome: Is bosentan treatment an option? Int J Cardiol 2009; 134: 378-383